Investigation: "Venture philanthropy" and a cystic fibrosis nonprofit's partnership with pharmaceutical company as it developed new drug.
"What happens when a disease-fighting charity dives into venture capitalism? In the first case of its kind, the results include one of the planet's most expensive pills, huge sales projections for a drug company and windfalls for executives who sold stock in the glow of enthusiastic news releases about the drug." -- John Fauber, the Milwaukee Journal Sentinel
